Merck Underscores Continued Commitment to Fighting Infectious Diseases With More than 25 Data Presentations at ECCMID 2017

Dateline City: KENILWORTH, N.J.KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that researchers are scheduled to provide more than 25 scientific data presentations on the company ’s established and investigational infectious disease medicines at this year’s 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 22-25 in Vienna, Austria.Language: EnglishContact: MerckMedia:Pam Eisele, 267-305-3558orRobert Consalvo, 908-295-0928orInvestor:Teri Loxam, 908-740-1986orAmy Klug, 908-740-1898Ticker Slug:Ticker:MRKExchange:NYSE @Merckread more
Source: Merck.com - Research and Development News - Category: Pharmaceuticals Tags: Research and Development News Corporate News Latest News #Merck #MRK $MRK ECCMID MSD NYSE:MRK Source Type: news